Logo image of GRVO.PA

GRAINES VOLTZ SA (GRVO.PA) Stock Fundamental Analysis

EPA:GRVO - FR0000065971 - Common Stock

20.1 EUR
-0.1 (-0.5%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall GRVO gets a fundamental rating of 3 out of 10. We evaluated GRVO against 4 industry peers in the Distributors industry. The financial health of GRVO is average, but there are quite some concerns on its profitability. GRVO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

GRVO had negative earnings in the past year.
In the past year GRVO had a positive cash flow from operations.
GRVO had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GRVO reported negative operating cash flow in multiple years.
GRVO.PA Yearly Net Income VS EBIT VS OCF VS FCFGRVO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.06%, GRVO is doing worse than 75.00% of the companies in the same industry.
GRVO's Return On Equity of -8.73% is in line compared to the rest of the industry. GRVO outperforms 50.00% of its industry peers.
The Return On Invested Capital of GRVO (2.46%) is worse than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GRVO is significantly below the industry average of 9.31%.
Industry RankSector Rank
ROA -4.06%
ROE -8.73%
ROIC 2.46%
ROA(3y)-0.06%
ROA(5y)2.68%
ROE(3y)-0.21%
ROE(5y)6.81%
ROIC(3y)2.52%
ROIC(5y)5.13%
GRVO.PA Yearly ROA, ROE, ROICGRVO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

Looking at the Operating Margin, with a value of 3.01%, GRVO is doing worse than 75.00% of the companies in the same industry.
GRVO's Operating Margin has declined in the last couple of years.
GRVO has a Gross Margin of 53.21%. This is amongst the best in the industry. GRVO outperforms 100.00% of its industry peers.
GRVO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.01%
PM (TTM) N/A
GM 53.21%
OM growth 3Y-34.24%
OM growth 5Y-16.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y9.9%
GRVO.PA Yearly Profit, Operating, Gross MarginsGRVO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

GRVO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GRVO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GRVO has been increased compared to 5 years ago.
Compared to 1 year ago, GRVO has a worse debt to assets ratio.
GRVO.PA Yearly Shares OutstandingGRVO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
GRVO.PA Yearly Total Debt VS Total AssetsGRVO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.33 indicates that GRVO is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of GRVO (2.33) is comparable to the rest of the industry.
The Debt to FCF ratio of GRVO is 16.25, which is on the high side as it means it would take GRVO, 16.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.25, GRVO is doing worse than 75.00% of the companies in the same industry.
A Debt/Equity ratio of 0.76 indicates that GRVO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.76, GRVO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 16.25
Altman-Z 2.33
ROIC/WACC0.59
WACC4.14%
GRVO.PA Yearly LT Debt VS Equity VS FCFGRVO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

GRVO has a Current Ratio of 1.94. This is a normal value and indicates that GRVO is financially healthy and should not expect problems in meeting its short term obligations.
GRVO has a Current ratio of 1.94. This is in the better half of the industry: GRVO outperforms 75.00% of its industry peers.
A Quick Ratio of 1.01 indicates that GRVO should not have too much problems paying its short term obligations.
GRVO's Quick ratio of 1.01 is amongst the best of the industry. GRVO outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.01
GRVO.PA Yearly Current Assets VS Current LiabilitesGRVO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

GRVO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -974.48%.
Looking at the last year, GRVO shows a small growth in Revenue. The Revenue has grown by 1.03% in the last year.
Measured over the past years, GRVO shows a quite strong growth in Revenue. The Revenue has been growing by 10.09% on average per year.
EPS 1Y (TTM)-974.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-497.53%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y3.2%
Revenue growth 5Y10.09%
Sales Q2Q%3.69%

3.2 Future

Based on estimates for the next years, GRVO will show a small growth in Earnings Per Share. The EPS will grow by 2.22% on average per year.
Based on estimates for the next years, GRVO will show a decrease in Revenue. The Revenue will decrease by -1.64% on average per year.
EPS Next Y45.43%
EPS Next 2Y-21.74%
EPS Next 3Y2.22%
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.64%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRVO.PA Yearly Revenue VS EstimatesGRVO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
GRVO.PA Yearly EPS VS EstimatesGRVO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRVO. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 3.87, which indicates a rather cheap valuation of GRVO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GRVO indicates a rather cheap valuation: GRVO is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of GRVO to the average of the S&P500 Index (22.69), we can say GRVO is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.87
GRVO.PA Price Earnings VS Forward Price EarningsGRVO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

GRVO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GRVO is cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GRVO indicates a somewhat cheap valuation: GRVO is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.21
EV/EBITDA 6.19
GRVO.PA Per share dataGRVO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.74%
EPS Next 3Y2.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GRVO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GRAINES VOLTZ SA

EPA:GRVO (9/5/2025, 7:00:00 PM)

20.1

-0.1 (-0.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.53%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.75M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.87
P/S 0.22
P/FCF 8.21
P/OCF 3.19
P/B 0.45
P/tB 0.66
EV/EBITDA 6.19
EPS(TTM)-3.94
EYN/A
EPS(NY)5.19
Fwd EY25.83%
FCF(TTM)2.45
FCFY12.19%
OCF(TTM)6.3
OCFY31.32%
SpS90.81
BVpS45.13
TBVpS30.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.06%
ROE -8.73%
ROCE 4.56%
ROIC 2.46%
ROICexc 2.64%
ROICexgc 3.27%
OM 3.01%
PM (TTM) N/A
GM 53.21%
FCFM 2.7%
ROA(3y)-0.06%
ROA(5y)2.68%
ROE(3y)-0.21%
ROE(5y)6.81%
ROIC(3y)2.52%
ROIC(5y)5.13%
ROICexc(3y)2.78%
ROICexc(5y)5.63%
ROICexgc(3y)3.51%
ROICexgc(5y)7.38%
ROCE(3y)4.46%
ROCE(5y)9.61%
ROICexcg growth 3Y-42.05%
ROICexcg growth 5Y-21.78%
ROICexc growth 3Y-40.13%
ROICexc growth 5Y-22.42%
OM growth 3Y-34.24%
OM growth 5Y-16.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y9.9%
F-Score5
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 16.25
Debt/EBITDA 6.57
Cap/Depr 154.53%
Cap/Sales 4.24%
Interest Coverage 2.11
Cash Conversion 120.54%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.01
Altman-Z 2.33
F-Score5
WACC4.14%
ROIC/WACC0.59
Cap/Depr(3y)149.77%
Cap/Depr(5y)250.46%
Cap/Sales(3y)4.25%
Cap/Sales(5y)5.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-974.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-497.53%
EPS Next Y45.43%
EPS Next 2Y-21.74%
EPS Next 3Y2.22%
EPS Next 5YN/A
Revenue 1Y (TTM)1.03%
Revenue growth 3Y3.2%
Revenue growth 5Y10.09%
Sales Q2Q%3.69%
Revenue Next Year2.33%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.64%
Revenue Next 5YN/A
EBIT growth 1Y64.94%
EBIT growth 3Y-32.14%
EBIT growth 5Y-7.53%
EBIT Next Year111.84%
EBIT Next 3Y19.66%
EBIT Next 5YN/A
FCF growth 1Y160.24%
FCF growth 3Y-16.53%
FCF growth 5YN/A
OCF growth 1Y644.28%
OCF growth 3Y-1.76%
OCF growth 5Y40.2%